Author

Raphael Gruber 1

1 Otsuka Pharmaceutical Europe Ltd., Frankfurt, Germany

EFFICACY AND SAFETY OF GRANULOCYTE, MONOCYTE/MACROPHAGE ADSORPTIVE APHERESIS IN STEROID-DEPENDENT ACTIVE UC WITH INSUFFICIENT RESPONSE OR INTOLERANCE TO IMMUNOSUPPRESSANTS AND/OR BIOLOGICAL THERAPIES (THE ART TRIAL): SAFETY RESULTS AT 12 WEEKS

Axel Dignass, Bruno Bonaz, Ayesha Akbar, Raphael Gruber

GRANULOCYTE, MONOCYTE/MACROPHAGE ADSORPTIVE APHERESIS IN STEROID-DEPENDENT ACTIVE UC WITH INSUFFICIENT RESPONSE OR INTOLERANCE TO IMMUNOSUPPRESSANTS AND/OR BIOLOGICAL THERAPIES (THE ART TRIAL): SAFETY RESULTS AT 48 WEEKS

Axel Dignass, Bruno Bonaz, Ayesha Akbar, Raphael Gruber

Item 1 - 2 / 3
1